The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Circadian Rhythm Sleep Disorders-Global Market Insights and Sales Trends 2025

Circadian Rhythm Sleep Disorders-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1814743

No of Pages : 89

Synopsis
Circadian rhythm sleep disorders are a group of sleep disorders characterized by disruptions in the sleep-wake cycle and the body's internal circadian rhythm. Examples include delayed sleep phase disorder, shift work sleep disorder, and jet lag disorder.
The global Circadian Rhythm Sleep Disorders market size is expected to reach US$ 1104.6 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Circadian Rhythm Sleep Disorders in various end use industries. The expanding demands from the Hospitals, Sleep Centers and Home Care Settings,, are propelling Circadian Rhythm Sleep Disorders market. Delayed Sleep Phase Disorder (DSP), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Jet Lag Disorder segment is estimated at % CAGR for the next seven-year period.
The market for circadian rhythm sleep disorder treatments and management is driven by the increasing awareness about the impact of circadian rhythm disruptions on overall health and well-being. The market's growth is also influenced by the demand for non-pharmacological and personalized approaches to address sleep disorders.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Circadian Rhythm Sleep Disorders, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Circadian Rhythm Sleep Disorders market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Circadian Rhythm Sleep Disorders market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Circadian Rhythm Sleep Disorders sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Circadian Rhythm Sleep Disorders covered in this report include Arena Pharmaceuticals, Boehringer Ingelheim, Fabre-Kramer Pharmaceuticals, Jazz Pharmaceuticals, Merck & Co, Glaxo Smith Kline, Respirerx Pharmaceuticals and Neurocrine Biosciences, etc.
The global Circadian Rhythm Sleep Disorders market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Arena Pharmaceuticals
Boehringer Ingelheim
Fabre-Kramer Pharmaceuticals
Jazz Pharmaceuticals
Merck & Co
Glaxo Smith Kline
Respirerx Pharmaceuticals
Neurocrine Biosciences
Global Circadian Rhythm Sleep Disorders market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Circadian Rhythm Sleep Disorders market, Segment by Type:
Delayed Sleep Phase Disorder (DSP)
Jet Lag Disorder
Irregular Sleep-Wake Rhythm
Free-Running (nonentrained) Type
Shift Work Disorder
Advanced Sleep Phase Disorder (ASP)
Global Circadian Rhythm Sleep Disorders market, by Application
Hospitals
Sleep Centers
Home Care Settings
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Circadian Rhythm Sleep Disorders companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Circadian Rhythm Sleep Disorders
1.1 Circadian Rhythm Sleep Disorders Market Overview
1.1.1 Circadian Rhythm Sleep Disorders Product Scope
1.1.2 Circadian Rhythm Sleep Disorders Market Status and Outlook
1.2 Global Circadian Rhythm Sleep Disorders Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Circadian Rhythm Sleep Disorders Market Size by Region (2018-2029)
1.4 Global Circadian Rhythm Sleep Disorders Historic Market Size by Region (2018-2023)
1.5 Global Circadian Rhythm Sleep Disorders Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.1 North America Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.2 Europe Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.3 Asia-Pacific Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.4 Latin America Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.5 Middle East & Africa Circadian Rhythm Sleep Disorders Market Size (2018-2029)
2 Circadian Rhythm Sleep Disorders Market by Type
2.1 Introduction
2.1.1 Delayed Sleep Phase Disorder (DSP)
2.1.2 Jet Lag Disorder
2.1.3 Irregular Sleep-Wake Rhythm
2.1.4 Free-Running (nonentrained) Type
2.1.5 Shift Work Disorder
2.1.6 Advanced Sleep Phase Disorder (ASP)
2.2 Global Circadian Rhythm Sleep Disorders Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Circadian Rhythm Sleep Disorders Historic Market Size by Type (2018-2023)
2.2.2 Global Circadian Rhythm Sleep Disorders Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
3 Circadian Rhythm Sleep Disorders Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Sleep Centers
3.1.3 Home Care Settings
3.2 Global Circadian Rhythm Sleep Disorders Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Circadian Rhythm Sleep Disorders Historic Market Size by Application (2018-2023)
3.2.2 Global Circadian Rhythm Sleep Disorders Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
4 Circadian Rhythm Sleep Disorders Competition Analysis by Players
4.1 Global Circadian Rhythm Sleep Disorders Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders as of 2022)
4.3 Date of Key Players Enter into Circadian Rhythm Sleep Disorders Market
4.4 Global Top Players Circadian Rhythm Sleep Disorders Headquarters and Area Served
4.5 Key Players Circadian Rhythm Sleep Disorders Product Solution and Service
4.6 Competitive Status
4.6.1 Circadian Rhythm Sleep Disorders Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Arena Pharmaceuticals
5.1.1 Arena Pharmaceuticals Profile
5.1.2 Arena Pharmaceuticals Main Business
5.1.3 Arena Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.1.4 Arena Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.1.5 Arena Pharmaceuticals Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.2.4 Boehringer Ingelheim Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Fabre-Kramer Pharmaceuticals
5.3.1 Fabre-Kramer Pharmaceuticals Profile
5.3.2 Fabre-Kramer Pharmaceuticals Main Business
5.3.3 Fabre-Kramer Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.3.4 Fabre-Kramer Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.3.5 Jazz Pharmaceuticals Recent Developments
5.4 Jazz Pharmaceuticals
5.4.1 Jazz Pharmaceuticals Profile
5.4.2 Jazz Pharmaceuticals Main Business
5.4.3 Jazz Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.4.4 Jazz Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.4.5 Jazz Pharmaceuticals Recent Developments
5.5 Merck & Co
5.5.1 Merck & Co Profile
5.5.2 Merck & Co Main Business
5.5.3 Merck & Co Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.5.4 Merck & Co Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.5.5 Merck & Co Recent Developments
5.6 Glaxo Smith Kline
5.6.1 Glaxo Smith Kline Profile
5.6.2 Glaxo Smith Kline Main Business
5.6.3 Glaxo Smith Kline Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.6.4 Glaxo Smith Kline Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.6.5 Glaxo Smith Kline Recent Developments
5.7 Respirerx Pharmaceuticals
5.7.1 Respirerx Pharmaceuticals Profile
5.7.2 Respirerx Pharmaceuticals Main Business
5.7.3 Respirerx Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.7.4 Respirerx Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.7.5 Respirerx Pharmaceuticals Recent Developments
5.8 Neurocrine Biosciences
5.8.1 Neurocrine Biosciences Profile
5.8.2 Neurocrine Biosciences Main Business
5.8.3 Neurocrine Biosciences Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.8.4 Neurocrine Biosciences Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.8.5 Neurocrine Biosciences Recent Developments
6 North America
6.1 North America Circadian Rhythm Sleep Disorders Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Circadian Rhythm Sleep Disorders Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Circadian Rhythm Sleep Disorders Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Circadian Rhythm Sleep Disorders Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Circadian Rhythm Sleep Disorders Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Circadian Rhythm Sleep Disorders Market Dynamics
11.1 Circadian Rhythm Sleep Disorders Industry Trends
11.2 Circadian Rhythm Sleep Disorders Market Drivers
11.3 Circadian Rhythm Sleep Disorders Market Challenges
11.4 Circadian Rhythm Sleep Disorders Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’